PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24226N0216Pluvicto (lutetium LU 177 vipivotide TETRA — Novartis Pharmaceuticals Corp

Novartis Pharmaceuticals Corp holds $23.5M across 59 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36F79720D0180. The prior award was single-bid — competitive dynamics may favor a challenge. Recompete timing centers on the Oct 31, 2026 PoP end — agencies typically plan 12–18 months ahead.

242-Network Contract Office 02 (36C242)
Awarding office
Novartis Pharmaceuticals Corp
Recipient
Oct 31, 2026
PoP end
$813K
Obligated
$813K
Potential
325412
NAICS
6505
PSC
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Novartis Pharmaceuticals Corp — $90

Contract facts

Federal
Contract number36C24226N0216
Also listed as36C242-26-N-0216
Also listed as36F79720D0180-36C24226N0216
Agency242-Network Contract Office 02 (36C242)
Awarding office242-Network Contract Office 02 (36C242)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentNovartis Pharmaceuticals Corp
CAGE04520
UEING61ZA8TADW3
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36F79720D0180
Place of performanceEAST HANOVER NJ
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
Related solicitation36C24226Q0080
PoP startNov 1, 2025
PoP end (current)Oct 31, 2026
Obligated$813K
Current value$813K
Potential value$813K

PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML) is a federal award for 242-Network Contract Office 02 (36C242) held by Novartis Pharmaceuticals Corp. Estimated value $813K ($813K obligated). Current period of performance ends Oct 31, 2026. Last award drew 1 bidder. Place of performance: EAST HANOVER NJ. Related solicitation 36C24226Q0080.

PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML)

Recompete timing

Public
Expiring in 71 days

Current PoP ends Oct 31, 2026 (71 days remaining). Agencies typically plan 12–18 months ahead — at 2.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Novartis Pharmaceuticals Corp$23.5M obligated across 59 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($23.5M) · all agencies
Department of Veterans Affairs (VA)$37.6M · 160%Department of Defense (DOD)$4.7M · 20%
Open full company profile

Related awards

Same parent · incumbent
36C24826F0082
PLUVICTO
$4.7M
Aug 31, 2026
36C25025F0726
PLUVICTO RADIOPHARMACEUTICAL - CLEVELAND VAMC
$400K
Aug 31, 2026
36C24125F0148
PLUVICTO
$810K
Sep 14, 2026
36C26126F0007
PLUVICTO DRUG
$4.0M
Sep 30, 2026
W81K0025FA195
LUTATHERA AND PLUVICTO
$3.2M
Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C24226N0216?

36C24226N0216 (Pluvicto (lutetium LU 177 vipivotide TETRA) is a 242-Network Contract Office 02 (36C242) award with a potential value of $813K, currently held by Novartis Pharmaceuticals Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C242-26-N-0216?

36C242-26-N-0216 is the dashed form of PIID 36C24226N0216 (Pluvicto (lutetium LU 177 vipivotide TETRA), held by Novartis Pharmaceuticals Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24226N0216?

242-Network Contract Office 02 (36C242) awarded 36C24226N0216 to Novartis Pharmaceuticals Corp (potential $813K).

Who is the incumbent on 36C24226N0216?

Novartis Pharmaceuticals Corp is the incumbent with $23.5M across 59 related awards in SCOUT’s public footprint. The current period of performance ends Oct 31, 2026.

When does Novartis Pharmaceuticals Corp’s 36C24226N0216 come up for recompete?

SCOUT tracks a period-of-performance end of Oct 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C24226N0216